US Drug Makers Push Profitable, But Unproven, Opioid Solution

Pilloried for their role in the epidemic of prescription painkiller abuse, U.S. drug makers are aggressively pushing their remedy to the problem: a new generation of harder-to-manipulate opioids that have racked up billions in sales, even though there's little proof they reduce rates of overdoses or deaths.   More than prescriptions are at stake. Critics worry the drug makers' nationwide lobbying campaign is distracting from more productive solutions and delaying crucial...

© La Voix de l'Amérique - jeudi 15 décembre 2016